New indication for Olumiant (baricitinib) as oral treatment for moderate to severe atopic dermatitis
EMA has recommended granting an extension of indication to Olumiant…
Roche announces FDA approval of FoundationOne Liquid CDx, a comprehensive pan-tumour liquid biopsy test
Roche has announced that the U.S. Food and Drug Administration (FDA) has…
Vaginal ring to reduce the risk of HIV infection for women in non-EU countries with high disease burden
EMA’s human medicines committee (CHMP) has adopted a positive opinion for…
Rozlytrek, Roche’s first tumour-agnostic therapy, approved in Europe for people with NTRK fusion-positive solid tumours and for people with ROS1-positive advanced non-small cell lung cancer
The European Commission has granted conditional marketing authorisation for…
Blenrep (belantamab mafodotin), new option for the treatment of relapsed and refractory multiple myeloma
EMA’s human medicines committee (CHMP) has recommended granting a conditional…
Inqovi (decitabine and cedazuridine), new Therapy for Myelodysplastic Syndromes (MDS) That Can Be Taken at Home
Inqovi (decitabine and cedazuridine) tablets is a new FDA approved treatment of…
Rukobia (fostemsavir), a new antiretroviral medication for patients who have run out of HIV treatment options
Rukobia (fostemsavir), is a newly approved type of antiretroviral medication…
Uplizna (inebilizumab-cdon)Therapy for Neuromyelitis Optica Spectrum Disorder Offers Patients Additional Treatment Option
The FDA has approved Uplizna (inebilizumab-cdon) injection for intravenous use…
FDA Approves Merck’s RECARBRIO (imipenem, cilastatin, and relebactam) for the Treatment of Adults with Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (HABP/VABP)
The FDA has approved a supplemental New Drug Application (sNDA) for RECARBRIO™…
FDA Approves Oriahnn (an estrogen and progestin combination product consisting of elagolix, estradiol and norethindrone acetate)to Treat Heavy Menstrual Bleeding Associated with Fibroids in Women
Oriahnn (an estrogen and progestin combination product consisting of elagolix,…